Advertisement
Screener

NRX Pharmaceuticals, Inc. (NRXP) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

NRX Pharmaceuticals, Inc. Number of Reportable Segments

NRX Pharmaceuticals, Inc. (NRXP) reported Number of Reportable Segments of 200.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfReportableSegments · last filed 2026-08-14

  • NRX Pharmaceuticals, Inc. number of reportable segments for the quarter ending 2026-03-31 was 200.00%, a 100.00% increase year-over-year.
  • NRX Pharmaceuticals, Inc. number of reportable segments for the quarter ending 2025-03-31 was 100.00%.
  • NRX Pharmaceuticals, Inc. number of reportable segments for fiscal 2025 was 200.00%, a 100.00% increase from fiscal 2024.
  • NRX Pharmaceuticals, Inc. number of reportable segments for fiscal 2024 was 100.00%.
Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-06-30200.00%
10-Q · filed 2026-08-14
2026-03-31200.00%
10-Q · filed 2026-05-15
2025-12-31200.00%
10-K · filed 2026-03-23
2025-09-30200.00%
10-Q · filed 2025-11-14
2025-06-30100.00%
10-Q · filed 2025-08-18
2025-03-31100.00%
10-Q · filed 2025-05-15
2024-12-31100.00%
10-K · filed 2025-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
MEDICINOVA INC (MNOV)United States$0.130B-6.04
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95